Zepbound: The Newest Weight Loss Drug
The Type 2 diabetes drug called tirzepatide was approved by the U.S. Food and Drug Administration (FDA) in November 2023 for treating chronic weight management. Sold under the brand name Mounjaro for treating diabetes, the drug will be called Zepbound when prescribed as a weight loss medication. In a nation that has become fascinated with … Read more